| | | | | | | California Stem Cell Report | | | | | | | | | | | | | | | | With only one business day remaining before its meeting this week, the California stem cell agency released details of its plan for an expensive study of its activities along with procedures for election of a new chairman. The late-coming information disclosed that the proposed Institute of Medicine study of CIRM would cost $615,000. Previously, CIRM discussions indicated that the cost would be | | | | | | | | | | | | | | | | | | | | | The California stem cell agency has hired a former executive of Geron Corp. to serve as a consultant on a $50 million clinical trial award round in which Geron is expected to be an applicant. He is Laurence Elias, who worked for Geron from March 2006 until October 2009 as vice president for oncology clinical development. In April, Nature Medicine identified Geron as one of the likely | | | | | | | | | | | | | |
No comments:
Post a Comment